Bionic Pancreas in Cystic Fibrosis related Diabetes
Do you have cystic fibrosis diabetes and using insulin? You may qualify for a research study evaluating a unique automated insulin delivery (aka artificial pancreas) for managing diabetes. The study is of 26 weeks duration. The compensation will be provided for research visits.
To be eligible for this study, you should:
- Be 14 years of age or older
- Have been diagnosed with cystic fibrosis and diabetes for at least three months
- Using insulin (either injection or pump) for at least one month
Efficacy and Safety of Medtronic 780G Automated Insulin Delivery System in Adults with Type 1 Diabetes and Gastroparesis
Managing diabetes in people with gastroparesis (delay in food digestion) could be challenging. In this study, we are evaluating Medtronic 780 G automated insulin delivery (aka artificial pancreas) to improve blood sugar and reduce burden of managing diabetes.
To be eligible for this study, you should:
- Be 18 years of age or older
- Have Type 1 diabetes and diagnosis of gastroparesis
- Using either insulin injection or insulin pump
Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes (EVOLVE)
This is a multi-center, 26-week randomized controlled trial (RCT) to evaluate the safety and efficacy of the fully closed loop Omnipod M System in adults with Type 2 diabetes using basal/bolus insulin therapy or basal-only insulin therapy.
To be eligible for this study, you should:
- Be 18 to 75 years of age
- Have Type 2 diabetes and on an insulin therapy
Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System (STRIVE 2)
This multi-center, randomized, cross-over trial will evaluate the efficacy of the Omnipod 6 System compared with the Omnipod 5 System in individuals with Type 1 or Type 2 diabetes.
To be eligible for this study, you should:
- Be 14 to 75 years of age
- Diagnosed with Type 1 diabetes for at least six month OR Type 2 diabetes at least one year
- On insulin therapy (either injection or insulin pump)
- Have a HbA1c of 7.5% or higher